Status:

COMPLETED

Inactivated Influenza Vaccine Effectiveness in Tropical Africa

Lead Sponsor:

PATH

Collaborating Sponsors:

Institut de Recherche pour le Developpement

Institut Pasteur

Conditions:

Influenza

Eligibility:

All Genders

6-10 years

Phase:

PHASE4

Brief Summary

Influenza, a highly communicable acute respiratory disease, is one of the major infectious disease threats to the human population. In Africa, information on the occurrence of influenza and its diseas...

Detailed Description

The trial will take place in the study area of the Niakhar demographic surveillance system in Senegal, a population representative of rural impoverished Africa. Villages will be randomized to TIV or a...

Eligibility Criteria

Inclusion

  • A male or female child at least 6 months of age and no older than 10 years of age (has not yet reached 11 years of age) at the enrollment visit.
  • A child whose parent or guardian's primary residence, at the time of study vaccinations, is a village compound selected to receive TIV or IPV.
  • Subject's parent or legal guardian is willing to provide written informed consent prior to the subject's first study vaccination.

Exclusion

  • Hypersensitivity to the active substance or any component in either TIV (which includes egg protein) or IPV. (Please see information on composition of vaccines.)
  • Hypersensitivity after previous administration of any influenza or polio vaccine.
  • Acute severe febrile illness. (Administration of TIV or IPV should be postponed until after recovery. Minor illnesses, such as mild upper respiratory infection, with or without low grade fever, are not reason for postponing vaccination. Acute severe febrile illness is only a temporary exclusion.)
  • Any condition that, in the opinion of the investigator, would pose a health risk to the participant or interfere with the evaluation of the study objectives.

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2013

Estimated Enrollment :

10000 Patients enrolled

Trial Details

Trial ID

NCT00893906

Start Date

May 1 2009

End Date

April 1 2013

Last Update

September 23 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Niakhar Demographic Surveillance System

Niakhar, Fatick District, Senegal